These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16446540)

  • 21. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome.
    Leung S; Gallup D; Mahaffey KW; Cohen M; Antman EM; Goodman SG; Harrington RA; Langer A; Aylward P; Ferguson JJ; Califf RM;
    Am Heart J; 2008 Jul; 156(1):177-84. PubMed ID: 18585514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous Magnesium Sulfate in Acute Stroke.
    Avgerinos KI; Chatzisotiriou A; Haidich AB; Tsapas A; Lioutas VA
    Stroke; 2019 Apr; 50(4):931-938. PubMed ID: 30852968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking Status and Functional Outcomes After Acute Ischemic Stroke.
    Matsuo R; Ago T; Kiyuna F; Sato N; Nakamura K; Kuroda J; Wakisaka Y; Kitazono T;
    Stroke; 2020 Mar; 51(3):846-852. PubMed ID: 31896344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Kumagai N; Origasa H; Nagao T; Takekawa H; Okuhara Y; Yamaguchi T
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):792-8. PubMed ID: 22633681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of tobacco smoking on clinimetric evaluation of stroke patients].
    Kaźmierski R; Michalak S; Adamczewska-Kociałkowska D; Kozubski W
    Przegl Lek; 2009; 66(10):561-4. PubMed ID: 20301880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline characteristics and treatment response of patients from the Philippines in the CHIMES study.
    Navarro JC; Gan HH; Lao AY; Baroque AC; Hiyadan JH; Chua CL; San Jose MC; Advincula JM; Lee CF; Bousser MG; Chen CL;
    Int J Stroke; 2014 Oct; 9 Suppl A100():102-5. PubMed ID: 25041870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical hyperthyroidism is a risk factor for poor functional outcome after ischemic stroke.
    Wollenweber FA; Zietemann V; Gschwendtner A; Opherk C; Dichgans M
    Stroke; 2013 May; 44(5):1446-8. PubMed ID: 23482604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial.
    Saver JL; Kidwell C; Eckstein M; Starkman S;
    Stroke; 2004 May; 35(5):e106-8. PubMed ID: 15017009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men.
    Kumagai N; Okuhara Y; Iiyama T; Fujimoto Y; Takekawa H; Origasa H; Kawanishi Y; Yamaguchi T
    J Neurol Sci; 2013 Dec; 335(1-2):164-8. PubMed ID: 24112970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke.
    Afshari D; Moradian N; Rezaei M
    Clin Neurol Neurosurg; 2013 Apr; 115(4):400-4. PubMed ID: 22749947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tirilazad mesylate in acute ischemic stroke: A systematic review. Tirilazad International Steering Committee.
    Stroke; 2000 Sep; 31(9):2257-65. PubMed ID: 10978061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective therapy for acute ischaemic stroke: down, but not out.
    Goldstein LB
    Lancet; 2004 Feb; 363(9407):414-5. PubMed ID: 14962518
    [No Abstract]   [Full Text] [Related]  

  • 33. On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke.
    Koziol JA; Feng AC
    Stroke; 2006 Oct; 37(10):2644-7. PubMed ID: 16946150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium for treatment of acute lacunar stroke syndromes: further analysis of the IMAGES trial.
    Aslanyan S; Weir CJ; Muir KW; Lees KR;
    Stroke; 2007 Apr; 38(4):1269-73. PubMed ID: 17347471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking is Not a Good Prognostic Factor following First-Ever Acute Ischemic Stroke.
    Lee JH; Lee JY; Ahn SH; Jang MU; Oh MS; Kim CH; Yu KH; Lee BC
    J Stroke; 2015 May; 17(2):177-91. PubMed ID: 26060805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke].
    Shamalov NA; Stakhovskaia LV; Shetova IM; Efremova NM; Anisimov KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):13-7. PubMed ID: 21462435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of smoking status on clinical outcomes after reperfusion therapy for acute ischemic stroke.
    Irie F; Matsuo R; Mezuki S; Wakisaka Y; Kamouchi M; Kitazono T; Ago T;
    Sci Rep; 2024 Apr; 14(1):9290. PubMed ID: 38654009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.
    Johnston KC; Li JY; Lyden PD; Hanson SK; Feasby TE; Adams RJ; Faught RE; Haley EC
    Stroke; 1998 Feb; 29(2):447-53. PubMed ID: 9472888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative aspects of using neuroprotectors in the management of patients with ischemic stroke].
    Ershov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):41-4. PubMed ID: 22224244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective agents in Acute Ischemic Stroke-A Reality Check.
    Goenka L; Uppugunduri Satyanarayana CR; S SK; George M
    Biomed Pharmacother; 2019 Jan; 109():2539-2547. PubMed ID: 30551514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.